Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study

Fig. 1

Kaplan–Meier and cumulative incidence curves for overall survival, progression-free survival, locoregional failure, and distant failure for greater than or equal to 5 versus fewer than 5 cycles of weekly low-dose cisplatin. OS: overall survival; PFS: progression-free survival; LRF: locoregional failure; DF: distant failure

Back to article page